About Bühlmann Laboratories
BÜHLMANN is a fully independent, medium sized and family owned Swiss company. Founded in 1976, BÜHLMANN today has local teams in Switzerland, France, Italy, Germany, Austria, USA and Brazil and distributors worldwide.
BÜHLMANN has become the prime calprotectin company within few years, offering the broadest range of calprotectin assays from fully automatable, high-throughput turbidimetric and ELISA assays, BÜHLMANN fCAL® turbo and BÜHLMANN fCAL® ELISA, to the point-of-care quantitative Quantum Blue® and IBDoc® home test application. Additional to calprotectin assays, BÜHLMANN offers therapeutic drug monitioring solutions for biologics used in chronic inflammatory diseases. BÜHLMANN does not only stand for calprotectin, but a selection of unique, high-quality assays for clinical routine use such as the BÜHLMANN Flow CAST® product group for Basophil Activation Testing, and the BÜHLMANN GanglioCombi™ products, the only screening ELISAs for anti-ganglioside testing. As unique as our products are our distribution fields with leading suppliers in the field of molecular diagnostics.
The Quality Management System is ISO 9001:2008 and 13485:2003 certified and the products are manufactured according to GMP standards.
- Focus : Manufacturer
- Employees: 11-50
- Industry : Diagnostics
Product portfolio of Bühlmann Laboratories
Here you will find Bühlmann Laboratories AG
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
